Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Comparative proteomic analysis of normal and tumor stromal cells by tissue on chip based mass spectrometry (toc-MS).

Escher N, Ernst G, Melle C, Berndt A, Clement JH, Junker K, Friedrich K, Guntinas-Lichius O, von Eggeling F.

Diagn Pathol. 2010 Jan 28;5:10. doi: 10.1186/1746-1596-5-10.

2.

Reference spectra from squamous epithelium and connective tissue allow whole section proteomics analysis.

Roesch-Ely M, Schnölzer M, Nees M, Plinkert PK, Bosch FX.

Arch Physiol Biochem. 2010 Oct-Dec;116(4-5):218-26. doi: 10.3109/13813455.2010.525240. Epub 2010 Nov 17.

PMID:
21080850
3.

Variability of in situ proteomic profiling and implications for study design in colorectal tumors.

Li JQ, Xu BJ, Shakhtour B, Deane N, Merchant N, Heslin MJ, Washington K, Coffey RJ, Beauchamp RD, Shyr Y, Billheimer D.

Int J Oncol. 2007 Jul;31(1):103-11.

PMID:
17549410
4.

Proteomic analysis of the stroma-related proteins in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues.

Li MX, Xiao ZQ, Chen YH, Peng F, Li C, Zhang PF, Li MY, Li F, Duan CJ, Li DJ, Yao HX, Chen ZC.

Med Oncol. 2010 Mar;27(1):134-44. doi: 10.1007/s12032-009-9184-1. Epub 2009 Feb 26.

PMID:
19242827
5.

Depicting the spatial distribution of proteins in human tumor tissue combining SELDI and MALDI imaging and immunohistochemistry.

Wehder L, Ernst G, Crecelius AC, Guntinas-Lichius O, Melle C, Schubert US, von Eggeling F.

J Histochem Cytochem. 2010 Oct;58(10):929-37. doi: 10.1369/jhc.2010.956656. Epub 2010 Jul 19.

6.

Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.

Brozkova K, Budinska E, Bouchal P, Hernychova L, Knoflickova D, Valik D, Vyzula R, Vojtesek B, Nenutil R.

Breast Cancer Res. 2008;10(3):R48. doi: 10.1186/bcr2101. Epub 2008 May 29.

7.

Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research.

von Eggeling F, Davies H, Lomas L, Fiedler W, Junker K, Claussen U, Ernst G.

Biotechniques. 2000 Nov;29(5):1066-70.

PMID:
11084869
8.

Quantitative proteomic analysis of differential proteins in the stroma of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue.

Li MX, Xiao ZQ, Liu YF, Chen YH, Li C, Zhang PF, Li MY, Li F, Peng F, Duan CJ, Yi H, Yao HX, Chen ZC.

J Cell Biochem. 2009 Mar 1;106(4):570-9. doi: 10.1002/jcb.22028.

PMID:
19142861
9.

MALDI mass spectrometry in prostate cancer biomarker discovery.

Flatley B, Malone P, Cramer R.

Biochim Biophys Acta. 2014 May;1844(5):940-9. doi: 10.1016/j.bbapap.2013.06.015. Epub 2013 Jul 2. Review.

PMID:
23831156
10.

Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS.

Sanders ME, Dias EC, Xu BJ, Mobley JA, Billheimer D, Roder H, Grigorieva J, Dowsett M, Arteaga CL, Caprioli RM.

J Proteome Res. 2008 Apr;7(4):1500-7. doi: 10.1021/pr7008109. Epub 2008 Apr 4.

11.

Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.

Baker H, Patel V, Molinolo AA, Shillitoe EJ, Ensley JF, Yoo GH, Meneses-García A, Myers JN, El-Naggar AK, Gutkind JS, Hancock WS.

Oral Oncol. 2005 Feb;41(2):183-99.

PMID:
15695121
12.
13.

2D-DIGE proteomic characterization of head and neck squamous cell carcinoma.

Merkley MA, Weinberger PM, Jackson LL, Podolsky RH, Lee JR, Dynan WS.

Otolaryngol Head Neck Surg. 2009 Nov;141(5):626-32. doi: 10.1016/j.otohns.2009.08.011.

14.

Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.

Sun S, Lee NP, Poon RT, Fan ST, He QY, Lau GK, Luk JM.

Liver Int. 2007 Oct;27(8):1021-38. Review.

PMID:
17845530
15.

Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry.

Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, Bogumil R, Moller U, Osterloh D, Halbhuber KJ, von Eggeling F.

Mol Cell Proteomics. 2003 Jul;2(7):443-52. Epub 2003 Jun 23.

16.

Proteomic analysis of gliomas.

Whittle IR, Short DM, Deighton RF, Kerr LE, Smith C, McCulloch J.

Br J Neurosurg. 2007 Dec;21(6):576-82. Review.

PMID:
18071984
17.

Identification of early intestinal neoplasia protein biomarkers using laser capture microdissection and MALDI MS.

Xu BJ, Li J, Beauchamp RD, Shyr Y, Li M, Washington MK, Yeatman TJ, Whitehead RH, Coffey RJ, Caprioli RM.

Mol Cell Proteomics. 2009 May;8(5):936-45. doi: 10.1074/mcp.M800345-MCP200. Epub 2009 Jan 21.

18.

Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.

Brown LM, Helmke SM, Hunsucker SW, Netea-Maier RT, Chiang SA, Heinz DE, Shroyer KR, Duncan MW, Haugen BR.

Mol Carcinog. 2006 Aug;45(8):613-26.

19.

Mass spectrometry meets chip technology: a new proteomic tool in cancer research?

von Eggeling F, Junker K, Fiedle W, Wollscheid V, Dürst M, Claussen U, Ernst G.

Electrophoresis. 2001 Aug;22(14):2898-902.

PMID:
11565785
20.

Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma.

Negishi A, Masuda M, Ono M, Honda K, Shitashige M, Satow R, Sakuma T, Kuwabara H, Nakanishi Y, Kanai Y, Omura K, Hirohashi S, Yamada T.

Cancer Sci. 2009 Sep;100(9):1605-11. doi: 10.1111/j.1349-7006.2009.01227.x. Epub 2009 May 18.

Supplemental Content

Support Center